Laurent Fischer - 15 May 2025 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role: CEO, PRESIDENT AND DIRECTOR, Director
Signature: /s/ Aneta Fergson, Attorney-in-Fact
Issuer symbol: ADVM
Transactions as of: 15 May 2025
Net transactions value: -$18,252
Form type: 4
Filing time: 16 May 2025, 16:44:20 UTC
Previous filing: 27 Feb 2025
Next filing: 02 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fischer Laurent	CEO, PRESIDENT AND DIRECTOR, Director	C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY	/s/ Aneta Fergson, Attorney-in-Fact	16 May 2025	0001379344

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADVM	Common Stock	Sale	$18,252	-9,126	-9.4%	$2.00	87,488	15 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
F2	Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.985 to $2.01. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.